Answers are grounded in this paper and cite their sources.
Contemporary clinical medicine confronts an epistemological crisis: the prevailing paradigm of chronic disease management treats pathologies such as Type 2 diabetes, malignant neoplasms, autoimmune diseases (e.g., Sjogren syndrome), and inflammatory dermatoses (e.g., atopic dermatitis) as lifelong degenerative conditions necessitating permanent palliative pharmacotherapy. Transcending reductionist symptom-suppression, this work formulates chronic disease as a non-equilibrium dynamical systems phenomenon: the stabilization of a maladaptive, self-reinforcing pathological attractor governed by non-linear feedback between somatic parenchyma and immune surveillance. Key Theoretical & Numerical Contributions: Canonical Four-Dimensional Dissipative Master Manifold: We introduce a unified four-dimensional non-negative state-space model governing functional parenchymal integrity (P), damaged or dysfunctional tissue burden (D), cytotoxic or inflammatory effector immunity (I_cyt), and regulatory self-tolerant homeostatic immunity (I_reg). Across all four distinct clinical archetypes, the phase space exhibits robust topological bistability separating a physiological health attractor (A_norm) from a chronic pathological attractor (A_path). Finite-Duration Pulsed Steering & Autonomous Curative Remission: Grounded in Willems' dissipative systems framework and Lyapunov barrier crossing, we prove that finite-duration pulsed multi-modal interventions driving the trajectory across the saddle-node separatrix achieve permanent, autonomous, recurrence-free remission without ongoing pharmacological maintenance. Numerical simulations across all four diseases demonstrate that while untreated cohorts remain permanently captured in the destructive attractor (P ≈ 0.07–0.11, D ≈ 0.43–0.63), a 50-day pulsed intervention (Days 20–70) achieves complete autonomous remission at Day 180—110 days after complete cessation of therapy (P = 0.8132–0.8825, D = 0.0241–0.0393). Universal Pre-Symptomatic Early Warning via Spectral Gap Softening: Operator-theoretic monitoring of the localized Koopman generator demonstrates that spectral gap softening (Omega_1 -> 0+) anticipates clinical tissue destruction (D > 0.25) across all four disease classes: 7.5 days in diabetes mellitus, 9.0 days in the tumor microenvironment, 10.7 days in Sjogren syndrome, and 6.2 days in atopic dermatitis. Open Science & Reproducibility: This grand synthesis unifies metabolic, neoplastic, autoimmune, and epithelial barrier disorders within the scale-invariant universality class of dissipative systems. The complete open-source Python simulation models, universal master ODE implementation, benchmark trajectory datasets, and phase-space visualization suites are publicly accessible under the MIT License at: https://github.com/sukuyoshi/The_Pathological_Attractor (This treatise synthesizes and extends the dissipative operator framework established in Yoshikai, 2026; DOI: 10.5281/zenodo.24156018, DOI: 10.5281/zenodo.24156142, DOI: 10.5281/zenodo.24156293, and DOI: 10.5281/zenodo.24156366).
No takes yet. Share an insight, caveat, or question.
Reiji Yoshikai (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: